Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Potential Self-Disinfection Capacity of Touch Screen Displays.

Hessling M, Spellerberg B, Hönes K.

J Biophotonics. 2019 Jun 20:e201900118. doi: 10.1002/jbio.201900118. [Epub ahead of print]

PMID:
31222906
2.

ESBL acquisition in Salmonella spp. and Shigella spp. in the context of systemic cephalosporin treatment.

Spellerberg B, Rabsch W, Pietsch M, Denzer C, Posovszky C, Essig A, Pfeifer Y.

Clin Infect Dis. 2019 Jun 4. pii: ciz468. doi: 10.1093/cid/ciz468. [Epub ahead of print] No abstract available.

PMID:
31165140
3.

Capsular Type, Sequence Type and Microbial Resistance Factors Impact on DNase Activity of Streptococcus agalactiae Strains from Human and Bovine Origin.

Florindo C, Barroco CA, Silvestre I, Damião V, Gomes JP, Spellerberg B, Santos-Sanches I, Borrego MJ.

Eur J Microbiol Immunol (Bp). 2018 Dec 11;8(4):149-154. doi: 10.1556/1886.2018.00026. eCollection 2018 Dec 23.

4.

405 nm and 450 nm Photoinactivation of Saccharomyces cerevisiae.

Hoenes K, Hess M, Vatter P, Spellerberg B, Hessling M.

Eur J Microbiol Immunol (Bp). 2018 Dec 6;8(4):142-148. doi: 10.1556/1886.2018.00023. eCollection 2018 Dec 23.

5.

Regulation of the β-hemolysin gene cluster of Streptococcus anginosus by CcpA.

Bauer R, Mauerer S, Spellerberg B.

Sci Rep. 2018 Jun 13;8(1):9028. doi: 10.1038/s41598-018-27334-z.

6.

Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.

Shabayek S, Spellerberg B.

Front Microbiol. 2018 Mar 14;9:437. doi: 10.3389/fmicb.2018.00437. eCollection 2018. Review.

7.

Molecular dynamics simulation of metal free structure of Lmb, a laminin-binding adhesin of Streptococcus agalactiae: metal removal and its structural implications.

Sridharan U, Ragunathan P, Spellerberg B, Ponnuraj K.

J Biomol Struct Dyn. 2019 Feb;37(3):714-725. doi: 10.1080/07391102.2018.1438923. Epub 2018 Feb 23.

PMID:
29421962
8.

The competence system of Streptococcus anginosus and its use for genetic engineering.

Bauer R, Mauerer S, Grempels A, Spellerberg B.

Mol Oral Microbiol. 2018 Apr;33(2):194-202. doi: 10.1111/omi.12213. Epub 2018 Feb 12.

PMID:
29290101
9.

Acid Stress Response Mechanisms of Group B Streptococci.

Shabayek S, Spellerberg B.

Front Cell Infect Microbiol. 2017 Sep 7;7:395. doi: 10.3389/fcimb.2017.00395. eCollection 2017. Review.

10.

Photoinactivation of Legionella Rubrilucens by Visible Light.

Schmid J, Hoenes K, Rath M, Vatter P, Spellerberg B, Hessling M.

Eur J Microbiol Immunol (Bp). 2017 Apr 26;7(2):146-149. doi: 10.1556/1886.2017.00006. eCollection 2017 Jun.

11.

Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B. Leitlinie des BVF, BVDfK, der DGGG, DGHM, DGPI, DGPM und GNPI. (S2k-Level, AWMF-Registernummer 024/020, März 2016).

Franz A, Härtel C, Herting E, Kehl S, Gille C, Doubek K, Spellerberg B, Maier RF, Vetter K, Eglin K.

Z Geburtshilfe Neonatol. 2017 Jun;221(3):122-129. doi: 10.1055/s-0043-105207. Epub 2017 Jun 30. German. No abstract available.

PMID:
28666303
12.

Reliable Detection of Group B Streptococcus in the Clinical Laboratory.

Rosa-Fraile M, Spellerberg B.

J Clin Microbiol. 2017 Sep;55(9):2590-2598. doi: 10.1128/JCM.00582-17. Epub 2017 Jun 28. Review.

13.

Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII.

Kuleshevich E, Ferretti J, Santos Sanches I, Balasubramanian N, Spellerberg B, Efstratiou A, Kriz P, Grabovskaya K, Arjanova O, Savitcheva A, Shevchenko V, Rysev A, Suvorov A.

Folia Microbiol (Praha). 2017 Sep;62(5):393-399. doi: 10.1007/s12223-017-0509-8. Epub 2017 Mar 18.

PMID:
28315021
14.

Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited.

Sendi P, El Hay MA, Brandt CM, Spellerberg B.

Emerg Infect Dis. 2017 Jan;23(1):150-152. doi: 10.3201/eid2301.161063.

15.

Photoinactivation of bacteria by endogenous photosensitizers and exposure to visible light of different wavelengths - a review on existing data.

Hessling M, Spellerberg B, Hoenes K.

FEMS Microbiol Lett. 2017 Jan;364(2). pii: fnw270. doi: 10.1093/femsle/fnw270. Epub 2016 Dec 2. Review.

PMID:
27915252
16.

Making Fluorescent Streptococci and Enterococci for Live Imaging.

Shabayek S, Spellerberg B.

Methods Mol Biol. 2017;1535:141-159.

PMID:
27914077
17.

A streptococcal NRAMP homologue is crucial for the survival of Streptococcus agalactiae under low pH conditions.

Shabayek S, Bauer R, Mauerer S, Mizaikoff B, Spellerberg B.

Mol Microbiol. 2016 May;100(4):589-606. doi: 10.1111/mmi.13335. Epub 2016 Feb 29.

18.

Laboratory Diagnosis of Streptococcus pyogenes (group A streptococci).

Spellerberg B, Brandt C.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

19.

Chromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiae.

Sendi P, Furitsch M, Mauerer S, Florindo C, Kahl BC, Shabayek S, Berner R, Spellerberg B.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1702-7. doi: 10.1128/AAC.01933-15.

20.

Non-haemolytic and non-pigmented group b streptococcus, an infrequent cause of early onset neonatal sepsis.

Rodriguez-Granger J, Spellerberg B, Asam D, Rosa-Fraile M.

Pathog Dis. 2015 Dec;73(9):ftv089. doi: 10.1093/femspd/ftv089. Epub 2015 Oct 7.

21.

Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity.

Asam D, Mauerer S, Spellerberg B.

Med Microbiol Immunol. 2015 Apr;204(2):227-37. doi: 10.1007/s00430-014-0363-0. Epub 2014 Nov 9.

PMID:
25381594
22.

Phenotypic and molecular characterization of hyperpigmented group B Streptococci.

Lupo A, Ruppen C, Hemphill A, Spellerberg B, Sendi P.

Int J Med Microbiol. 2014 Jul;304(5-6):717-24. doi: 10.1016/j.ijmm.2014.05.003. Epub 2014 May 16.

PMID:
24933304
23.

Molecular pathogenicity of Streptococcus anginosus.

Asam D, Spellerberg B.

Mol Oral Microbiol. 2014 Aug;29(4):145-55. doi: 10.1111/omi.12056. Epub 2014 Jun 26. Review.

PMID:
24848553
24.

Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre.

Fröhlicher S, Reichen-Fahrni G, Müller M, Surbek D, Droz S, Spellerberg B, Sendi P.

Swiss Med Wkly. 2014 Mar 20;144:w13935. doi: 10.4414/smw.2014.13935.

25.

Group B streptococcal haemolysin and pigment, a tale of twins.

Rosa-Fraile M, Dramsi S, Spellerberg B.

FEMS Microbiol Rev. 2014 Sep;38(5):932-46. doi: 10.1111/1574-6976.12071. Epub 2014 Apr 4. Review.

26.

Metal binding is critical for the folding and function of laminin binding protein, Lmb of Streptococcus agalactiae.

Ragunathan P, Sridaran D, Weigel A, Shabayek S, Spellerberg B, Ponnuraj K.

PLoS One. 2013 Jun 24;8(6):e67517. doi: 10.1371/journal.pone.0067517. Print 2013.

27.

Identification of β-haemolysin-encoding genes in Streptococcus anginosus.

Asam D, Mauerer S, Walheim E, Spellerberg B.

Mol Oral Microbiol. 2013 Aug;28(4):302-15. doi: 10.1111/omi.12026. Epub 2013 Apr 18.

PMID:
23594064
28.

The β-hemolysin and intracellular survival of Streptococcus agalactiae in human macrophages.

Sagar A, Klemm C, Hartjes L, Mauerer S, van Zandbergen G, Spellerberg B.

PLoS One. 2013 Apr 4;8(4):e60160. doi: 10.1371/journal.pone.0060160. Print 2013.

29.

Selection of reference genes for real-time expression studies in Streptococcus agalactiae.

Florindo C, Ferreira R, Borges V, Spellerberg B, Gomes JP, Borrego MJ.

J Microbiol Methods. 2012 Sep;90(3):220-7. doi: 10.1016/j.mimet.2012.05.011. Epub 2012 May 23.

PMID:
22634000
30.

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2097-104. Review.

PMID:
22314410
31.

Genetic differences between invasive and noninvasive neonatal group B streptococcal isolates.

Fluegge K, Wons J, Spellerberg B, Swoboda S, Siedler A, Hufnagel M, Berner R.

Pediatr Infect Dis J. 2011 Dec;30(12):1027-31. doi: 10.1097/INF.0b013e31822a2a1f.

PMID:
21775921
32.

High-level fluorescence labeling of gram-positive pathogens.

Aymanns S, Mauerer S, van Zandbergen G, Wolz C, Spellerberg B.

PLoS One. 2011;6(6):e19822. doi: 10.1371/journal.pone.0019822. Epub 2011 Jun 22.

33.

In vitro transcriptome analysis of porcine choroid plexus epithelial cells in response to Streptococcus suis: release of pro-inflammatory cytokines and chemokines.

Schwerk C, Adam R, Borkowski J, Schneider H, Klenk M, Zink S, Quednau N, Schmidt N, Stump C, Sagar A, Spellerberg B, Tenenbaum T, Koczan D, Klein-Hitpass L, Schroten H.

Microbes Infect. 2011 Oct;13(11):953-62. doi: 10.1016/j.micinf.2011.05.012. Epub 2011 Jun 12.

PMID:
21683799
34.

The FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells.

Amelung S, Nerlich A, Rohde M, Spellerberg B, Cole JN, Nizet V, Chhatwal GS, Talay SR.

Cell Microbiol. 2011 Aug;13(8):1200-11. doi: 10.1111/j.1462-5822.2011.01610.x. Epub 2011 May 25.

35.

Group A streptococcal vertebral osteomyelitis presenting with acute quadriplegia.

Furitsch M, Träger K, van der Linden M, Spellerberg B.

Infection. 2011 Aug;39(4):389-91. doi: 10.1007/s15010-011-0113-9. Epub 2011 Apr 22. No abstract available.

PMID:
21512790
36.

Molecular epidemiology of group B streptococcal meningitis in children beyond the neonatal period from Angola.

Florindo C, Gomes JP, Rato MG, Bernardino L, Spellerberg B, Santos-Sanches I, Borrego MJ.

J Med Microbiol. 2011 Sep;60(Pt 9):1276-80. doi: 10.1099/jmm.0.031674-0. Epub 2011 Apr 7.

PMID:
21474607
37.

Enhanced expression of lmb gene encoding laminin-binding protein in Streptococcus agalactiae strains harboring IS1548 in scpB-lmb intergenic region.

Al Safadi R, Amor S, Hery-Arnaud G, Spellerberg B, Lanotte P, Mereghetti L, Gannier F, Quentin R, Rosenau A.

PLoS One. 2010 May 24;5(5):e10794. doi: 10.1371/journal.pone.0010794.

38.

Structure of laminin-binding adhesin (Lmb) from Streptococcus agalactiae.

Ragunathan P, Spellerberg B, Ponnuraj K.

Acta Crystallogr D Biol Crystallogr. 2009 Dec;65(Pt 12):1262-9. doi: 10.1107/S0907444909038359. Epub 2009 Nov 17.

PMID:
19966412
39.

Human infections due to Streptococcus dysgalactiae subspecies equisimilis.

Brandt CM, Spellerberg B.

Clin Infect Dis. 2009 Sep 1;49(5):766-72. doi: 10.1086/605085.

PMID:
19635028
40.

Human serum induces streptococcal c5a peptidase expression.

Gleich-Theurer U, Aymanns S, Haas G, Mauerer S, Vogt J, Spellerberg B.

Infect Immun. 2009 Sep;77(9):3817-25. doi: 10.1128/IAI.00826-08. Epub 2009 Jun 8.

41.

Expression, purification, crystallization and preliminary crystallographic analysis of laminin-binding protein (Lmb) from Streptococcus agalactiae.

Ragunathan P, Spellerberg B, Ponnuraj K.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 May 1;65(Pt 5):492-4. doi: 10.1107/S1744309109012743. Epub 2009 Apr 24.

42.

Rapid identification of beta-hemolytic streptococci by fluorescence in situ hybridization (FISH).

Poppert S, Nickel D, Berger A, Yildiz T, Kaestner N, Mauerer S, Spellerberg B.

Int J Med Microbiol. 2009 Aug;299(6):421-6. doi: 10.1016/j.ijmm.2009.02.001. Epub 2009 Apr 2.

PMID:
19345144
43.

Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein-labeled Escherichia coli and group B Streptococci.

Gille Ch, Leiber A, Mundle I, Spring B, Abele H, Spellerberg B, Hartmann H, Poets ChF, Orlikowsky TW.

Cytometry B Clin Cytom. 2009 Jul;76(4):271-84. doi: 10.1002/cyto.b.20474.

44.

Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Eickel V, Kahl B, Reinisch B, Dübbers A, Küster P, Brandt C, Spellerberg B.

PLoS One. 2009;4(2):e4650. doi: 10.1371/journal.pone.0004650. Epub 2009 Feb 27.

45.

Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis.

Sigge A, Schmid M, Mauerer S, Spellerberg B.

J Clin Microbiol. 2008 Feb;46(2):807-9. Epub 2007 Dec 12.

46.

[Subcutaneous emphysema of unusual extent].

Besier S, Bingold TM, Walcher F, Engels K, Spellerberg B, Brade V, Brandt C.

Chirurg. 2007 Dec;78(12):1148-51. German.

PMID:
17431554
47.

Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb.

Tenenbaum T, Spellerberg B, Adam R, Vogel M, Kim KS, Schroten H.

Microbes Infect. 2007 May;9(6):714-20. Epub 2007 Feb 24.

PMID:
17400016
48.

Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter.

Gottschalk B, Bröker G, Kuhn M, Aymanns S, Gleich-Theurer U, Spellerberg B.

J Bacteriol. 2006 Aug;188(16):5984-92.

49.

Epidemiology of Streptococcus agalactiae colonization in Germany.

Brimil N, Barthell E, Heindrichs U, Kuhn M, Lütticken R, Spellerberg B.

Int J Med Microbiol. 2006 Feb;296(1):39-44. Epub 2005 Dec 19.

PMID:
16361113
50.

ISSag1 in streptococcal strains of human and animal origin.

Franken C, Brandt C, Bröker G, Spellerberg B.

Int J Med Microbiol. 2004 Oct;294(4):247-54.

PMID:
15532982

Supplemental Content

Loading ...
Support Center